Michael J. Connor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Michael J. Connor has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
Charbel Salem
Cleveland Clinic, Cleveland, Ohio
5 shared publicationsSeth R. Bauer
Cleveland Clinic, Cleveland, Ohio
4 shared publicationsAnitha Vijayan
Division of Nephrology, Washington University School of Medicine, St. Louis, USA
3 shared publicationsAshita Tolwani
Division of Nephrology, Department of Medicine, University of Alabama, Birmingham, USA
3 shared publications- Azra Bihorac
Intelligent Clinical Care Center, University of Florida, Gainesville, Florida
3 shared publications Ian Crozier
Infectious Diseases Institute, Mulago Hospital Complex, Kampala, Uganda
3 shared publications
Latest Publications
- Open Access
- 8 August 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (10) , 1798-1809
Proceedings of the University of Alabama at Birmingham Continuous Renal Replacement Therapy Academy (2023–2024)
In this second installment of the proceedings of the University of Alabama at Birmingham Continuous Renal Replacement Therapy (CRRT) Academy, we focus on the topic of transitions of care in acute renal replacement therapy (RRT). Although we have accumulated data from thousands of critically ill patients with AKI randomized to different strategies for RRT initiation, no trial data exist to guide de-escalation of RRT in the intensive care unit. However, for survivors of severe AKI whose kidney function does not recovery rapidly enough to allow for liberation directly from CRRT, successful de-escalation of care requires the transition from CRRT to intermittent RRT modalities. These transition periods must be carefully navigated since they can be a source of complications, such as failure to transition or intradialytic hypotension, which are in turn associated with an increased risk of mortality and reduced odds of kidney recovery. In this review, we focus on the critical factors to consider during de-escalation of RRT care, with a focus on modality transition, the role of volume status in guiding the approach to de-escalation of RRT, and the vital importance of careful dosing of drugs, especially antimicrobial agents, during this transitional period.
- 8 August 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (10) , 1798-1809
Open AccessProceedings of the University of Alabama at Birmingham Continuous Renal Replacement Therapy Academy (2023–2024)
In this second installment of the proceedings of the University of Alabama at Birmingham Continuous Renal Replacement Therapy (CRRT) Academy, we focus on the topic of transitions of care in acute renal replacement therapy (RRT). Although we have accumulated data from thousands of critically ill patients with AKI randomized to different strategies for RRT initiation, no trial data exist to guide de-escalation of RRT in the intensive care unit. However, for survivors of severe AKI whose kidney function does not recovery rapidly enough to allow for liberation directly from CRRT, successful de-escalation of care requires the transition from CRRT to intermittent RRT modalities. These transition periods must be carefully navigated since they can be a source of complications, such as failure to transition or intradialytic hypotension, which are in turn associated with an increased risk of mortality and reduced odds of kidney recovery. In this review, we focus on the critical factors to consider during de-escalation of RRT care, with a focus on modality transition, the role of volume status in guiding the approach to de-escalation of RRT, and the vital importance of careful dosing of drugs, especially antimicrobial agents, during this transitional period.
- Open Access
- 20 March 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (8) , 1270-1272
Physiologic Solutions are Superior to Normal Saline in Critically Ill Patients: PRO
An abstract is unavailable. This article is available as a PDF only.
- 20 March 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (8) , 1270-1272
Open AccessPhysiologic Solutions are Superior to Normal Saline in Critically Ill Patients: PRO
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 1 September 2021
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 27 (5) , 353-363
Precision Radiotherapy for Gliomas
Gliomas are the most common primary brain cancer, yet are extraordinarily challenging to treat because they can be aggressive and infiltrative, locally recurrent, and resistant to standard treatments. Furthermore, the treatments themselves, including radiation therapy, can affect patients' neurocognitive function and quality of life. Noninvasive imaging is the standard of care for primary brain tumors, including diagnosis, treatment planning, and monitoring for treatment response. This article explores the ways in which advanced imaging has and will continue to transform radiation treatment for patients with gliomas, with a focus on cognitive preservation and novel biomarkers, as well as precision radiotherapy and treatment adaptation. Advances in novel imaging techniques continue to push the field forward, to more precisely guided treatment planning, radiation dose escalation, measurement of therapeutic response, and understanding of radiation-associated injury.
- 1 September 2021
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 27 (5) , 353-363
Open AccessPrecision Radiotherapy for Gliomas
Gliomas are the most common primary brain cancer, yet are extraordinarily challenging to treat because they can be aggressive and infiltrative, locally recurrent, and resistant to standard treatments. Furthermore, the treatments themselves, including radiation therapy, can affect patients' neurocognitive function and quality of life. Noninvasive imaging is the standard of care for primary brain tumors, including diagnosis, treatment planning, and monitoring for treatment response. This article explores the ways in which advanced imaging has and will continue to transform radiation treatment for patients with gliomas, with a focus on cognitive preservation and novel biomarkers, as well as precision radiotherapy and treatment adaptation. Advances in novel imaging techniques continue to push the field forward, to more precisely guided treatment planning, radiation dose escalation, measurement of therapeutic response, and understanding of radiation-associated injury.
- 23 August 2021
- Published by Wiley in Seminars in Dialysis
- Vol. 34 (6) , 510-517
Organizational and financial aspects of a continuous renal replacement therapy program
Critically ill patients who develop severe acute kidney injury in the intensive care unit often require treatment with renal replacement therapies (RRTs). This complication is associated with severe morbidity and mortality and high costs, both during hospitalization and postdischarge. This article discusses the operational requirements to develop and conduct a RRT program, as well as the financial implications of this complex form of patient care. The management of these programs must occur in a context where a clear organizational and educational framework and a multidisciplinary team ensures safety, effectiveness, cost-control, and a clear quality control framework.
- 23 August 2021
- Published by Wiley in Seminars in Dialysis
- Vol. 34 (6) , 510-517
Organizational and financial aspects of a continuous renal replacement therapy program
Critically ill patients who develop severe acute kidney injury in the intensive care unit often require treatment with renal replacement therapies (RRTs). This complication is associated with severe morbidity and mortality and high costs, both during hospitalization and postdischarge. This article discusses the operational requirements to develop and conduct a RRT program, as well as the financial implications of this complex form of patient care. The management of these programs must occur in a context where a clear organizational and educational framework and a multidisciplinary team ensures safety, effectiveness, cost-control, and a clear quality control framework.
- Open Access
- 2 November 2020
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 16 (12) , 765
Publisher Correction: COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 2 November 2020
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 16 (12) , 765
Open AccessPublisher Correction: COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- Top Cited PapersOpen Access
- 15 October 2020
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 16 (12) , 747-764
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) requiring renal replacement therapy (RRT; also known as kidney replacement therapy). COVID-19-associated AKI (COVID-19 AKI) is associated with high mortality and serves as an independent risk factor for all-cause in-hospital death in patients with COVID-19. The pathophysiology and mechanisms of AKI in patients with COVID-19 have not been fully elucidated and seem to be multifactorial, in keeping with the pathophysiology of AKI in other patients who are critically ill. Little is known about the prevention and management of COVID-19 AKI. The emergence of regional ‘surges’ in COVID-19 cases can limit hospital resources, including dialysis availability and supplies; thus, careful daily assessment of available resources is needed. In this Consensus Statement, the Acute Disease Quality Initiative provides recommendations for the diagnosis, prevention and management of COVID-19 AKI based on current literature. We also make recommendations for areas of future research, which are aimed at improving understanding of the underlying processes and improving outcomes for patients with COVID-19 AKI.
- 15 October 2020
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 16 (12) , 747-764
Top Cited PapersOpen AccessCOVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) requiring renal replacement therapy (RRT; also known as kidney replacement therapy). COVID-19-associated AKI (COVID-19 AKI) is associated with high mortality and serves as an independent risk factor for all-cause in-hospital death in patients with COVID-19. The pathophysiology and mechanisms of AKI in patients with COVID-19 have not been fully elucidated and seem to be multifactorial, in keeping with the pathophysiology of AKI in other patients who are critically ill. Little is known about the prevention and management of COVID-19 AKI. The emergence of regional ‘surges’ in COVID-19 cases can limit hospital resources, including dialysis availability and supplies; thus, careful daily assessment of available resources is needed. In this Consensus Statement, the Acute Disease Quality Initiative provides recommendations for the diagnosis, prevention and management of COVID-19 AKI based on current literature. We also make recommendations for areas of future research, which are aimed at improving understanding of the underlying processes and improving outcomes for patients with COVID-19 AKI.
- Open Access
- 1 July 2020
- Published by Elsevier in Kidney International Reports
- Vol. 5 (7) , 961-964
Preparedness of Kidney Replacement Therapy in the Critically Ill During COVID-19 Surge
- 1 July 2020
- Published by Elsevier in Kidney International Reports
- Vol. 5 (7) , 961-964
Open AccessPreparedness of Kidney Replacement Therapy in the Critically Ill During COVID-19 Surge
- 1 December 2018
- Published by Wolters Kluwer Health in Current Opinion in Critical Care
- Vol. 24 (6) , 493-503
Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how?
Purpose of review: The use of extracorporeal membrane oxygenation (ECMO) is increasing rapidly. Patients on ECMO have a high risk of developing acute kidney injury (AKI) and needing renal replacement therapy (RRT). The aim of this review is to describe different strategies of combining RRT and ECMO and to outline their advantages and drawbacks. Recent findings: Fluid overload is the most common indication for RRT during ECMO, and continuous renal replacement therapy (CRRT) is the most commonly used modality. The optimal timing for initiation of CRRT should be individualized based on degree of fluid overload and severity of AKI-related metabolic derangements. In ECMO patients, CRRT can be provided via an integrated approach (i.e. in-line haemofilter or a fully integrated CRRT device) or a parallel system with separate ECMO and RRT circuits. In-depth knowledge of the resulting intra-circuit pressure changes, risks of air entrapment and haemolysis, and implications for ultrafiltration and solute clearance are essential. There is no evidence that the different methods of combining ECMO and CRRT impact mortality. Summary: In patients on ECMO, CRRT can be provided via an integrated approach or independently via parallel systems. An in-depth understanding of the advantages and drawbacks of the different techniques is required.
- 1 December 2018
- Published by Wolters Kluwer Health in Current Opinion in Critical Care
- Vol. 24 (6) , 493-503
Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how?
Purpose of review: The use of extracorporeal membrane oxygenation (ECMO) is increasing rapidly. Patients on ECMO have a high risk of developing acute kidney injury (AKI) and needing renal replacement therapy (RRT). The aim of this review is to describe different strategies of combining RRT and ECMO and to outline their advantages and drawbacks. Recent findings: Fluid overload is the most common indication for RRT during ECMO, and continuous renal replacement therapy (CRRT) is the most commonly used modality. The optimal timing for initiation of CRRT should be individualized based on degree of fluid overload and severity of AKI-related metabolic derangements. In ECMO patients, CRRT can be provided via an integrated approach (i.e. in-line haemofilter or a fully integrated CRRT device) or a parallel system with separate ECMO and RRT circuits. In-depth knowledge of the resulting intra-circuit pressure changes, risks of air entrapment and haemolysis, and implications for ultrafiltration and solute clearance are essential. There is no evidence that the different methods of combining ECMO and CRRT impact mortality. Summary: In patients on ECMO, CRRT can be provided via an integrated approach or independently via parallel systems. An in-depth understanding of the advantages and drawbacks of the different techniques is required.
- 20 February 2018
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 13 (5) , 787-789
Management of Severe Hyponatremia with Continuous Renal Replacement Therapies
- 20 February 2018
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 13 (5) , 787-789
Management of Severe Hyponatremia with Continuous Renal Replacement Therapies
- 18 December 2017
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 33 (3) , 439-446
Micronutrient Alterations During Continuous Renal Replacement Therapy in Critically Ill Adults: A Retrospective Study
Background: Continuous renal replacement therapy (CRRT) is commonly used to provide renal replacement therapy in the intensive care unit. Limited published data suggest that CRRT may lead to depletion of water‐soluble vitamins and trace elements. The goal of this study was to identify the incidence of trace element and vitamin deficiencies in critically ill patients during CRRT. Materials and Methods: This study is based on a retrospective chart review of patients who were referred to Emory University Hospital’s nutrition support services and had at least 1 serum micronutrient level measured during CRRT (thiamin, pyridoxine, ascorbic acid, folate, zinc, and copper) between April 1, 2009, and June 1, 2012. Results: Seventy‐five patients were included in the study. Nine of 56 patients (16%) had below‐normal whole blood thiamin concentrations, and 38 of 57 patients (67%) had below‐normal serum pyridoxine levels. Serum ascorbic acid and folate deficiencies were identified among 87% (13 of 15) and 33% (3 of 9) of the study patients, respectively. Nine of 24 patients had zinc deficiency (38%), and 41 of 68 patients had copper deficiency (60%). Of the 75 total subjects, 60 patients (80%) had below‐normal levels of at least 1 of the micronutrients measured. Conclusions: The incidence of various micronutrient deficiencies in critically ill patients who required CRRT was higher than previously reported. Prospective studies are needed to determine the impact of CRRT on micronutrient status and the potential clinical and metabolic efficacy of supplementation in the intensive care unit setting.
- 18 December 2017
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 33 (3) , 439-446
Micronutrient Alterations During Continuous Renal Replacement Therapy in Critically Ill Adults: A Retrospective Study
Background: Continuous renal replacement therapy (CRRT) is commonly used to provide renal replacement therapy in the intensive care unit. Limited published data suggest that CRRT may lead to depletion of water‐soluble vitamins and trace elements. The goal of this study was to identify the incidence of trace element and vitamin deficiencies in critically ill patients during CRRT. Materials and Methods: This study is based on a retrospective chart review of patients who were referred to Emory University Hospital’s nutrition support services and had at least 1 serum micronutrient level measured during CRRT (thiamin, pyridoxine, ascorbic acid, folate, zinc, and copper) between April 1, 2009, and June 1, 2012. Results: Seventy‐five patients were included in the study. Nine of 56 patients (16%) had below‐normal whole blood thiamin concentrations, and 38 of 57 patients (67%) had below‐normal serum pyridoxine levels. Serum ascorbic acid and folate deficiencies were identified among 87% (13 of 15) and 33% (3 of 9) of the study patients, respectively. Nine of 24 patients had zinc deficiency (38%), and 41 of 68 patients had copper deficiency (60%). Of the 75 total subjects, 60 patients (80%) had below‐normal levels of at least 1 of the micronutrients measured. Conclusions: The incidence of various micronutrient deficiencies in critically ill patients who required CRRT was higher than previously reported. Prospective studies are needed to determine the impact of CRRT on micronutrient status and the potential clinical and metabolic efficacy of supplementation in the intensive care unit setting.